224 related articles for article (PubMed ID: 10355059)
1. [Treatment with immunoglobulins].
Junker U
Z Arztl Fortbild Qualitatssich; 1999 Mar; 93(2):105-9. PubMed ID: 10355059
[TBL] [Abstract][Full Text] [Related]
2. [Intravenous immunoglobulin therapy].
Mouthon L
Rev Prat; 2005 May; 55(10):1049-56. PubMed ID: 16097244
[TBL] [Abstract][Full Text] [Related]
3. [New indications for the use of immunoglobulins].
Morell A; Imbach P; Heiniger HJ
Beitr Infusionsther; 1989; 24():122-33. PubMed ID: 2481529
[TBL] [Abstract][Full Text] [Related]
4. [Immunoglobulins and immune deficiency: methods of administration].
Suarez F
Rev Med Interne; 2005 Oct; 26 Spec No 1():25-8. PubMed ID: 16475260
[No Abstract] [Full Text] [Related]
5. Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology.
Orange JS; Hossny EM; Weiler CR; Ballow M; Berger M; Bonilla FA; Buckley R; Chinen J; El-Gamal Y; Mazer BD; Nelson RP; Patel DD; Secord E; Sorensen RU; Wasserman RL; Cunningham-Rundles C;
J Allergy Clin Immunol; 2006 Apr; 117(4 Suppl):S525-53. PubMed ID: 16580469
[TBL] [Abstract][Full Text] [Related]
6. Management of primary antibody deficiency with replacement therapy: summary of guidelines.
Roifman CM; Berger M; Notarangelo LD
Immunol Allergy Clin North Am; 2008 Nov; 28(4):875-6, x. PubMed ID: 18940580
[TBL] [Abstract][Full Text] [Related]
7. Europe immunoglobulin map.
Šedivá A; Chapel H; Gardulf A;
Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):141-3. PubMed ID: 25546797
[No Abstract] [Full Text] [Related]
8. Dose and outcomes in primary immunodeficiency disorders.
Bonagura VR
Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):7-9. PubMed ID: 25546743
[No Abstract] [Full Text] [Related]
9. [Intravenous substitution with immunoglobulins].
Zielinski CC; Eibl MM
Wien Klin Wochenschr; 1991; 103(17):524-7. PubMed ID: 1949811
[TBL] [Abstract][Full Text] [Related]
10. [Intravenous immunoglobulins. Basic principles, selection criteria and indications for preventive and therapeutic administration].
Böger RH; Bode-Böger SM; Frölich JC
Med Klin (Munich); 1995 Sep; 90(9):520-6. PubMed ID: 7476730
[No Abstract] [Full Text] [Related]
11. [Current applications of immunoglobulin therapy].
Helmke K
Fortschr Med; 1994 May; 112(15):213-7. PubMed ID: 8050765
[TBL] [Abstract][Full Text] [Related]
12. Guidelines for the use of human immunoglobulin therapy in patients with primary immunodeficiencies in Latin America.
Condino-Neto A; Costa-Carvalho BT; Grumach AS; King A; Bezrodnik L; Oleastro M; Leiva L; Porras O; Espinosa-Rosales FJ; Franco JL; Sorensen RU
Allergol Immunopathol (Madr); 2014; 42(3):245-60. PubMed ID: 23333411
[TBL] [Abstract][Full Text] [Related]
13. Protein-glycan interactions as targets of intravenous/subcutaneous immunoglobulin (IVIg/SCIg) preparations.
von Gunten S
Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):151-2. PubMed ID: 25546801
[No Abstract] [Full Text] [Related]
14. [Indications for intravenous immunoglobulins].
Spertini F
Rev Med Suisse Romande; 1993 Mar; 113(3):179-82. PubMed ID: 8480110
[No Abstract] [Full Text] [Related]
15. The use of intravenous immune globulin in immunodeficiency diseases.
Buckley RH; Schiff RI
N Engl J Med; 1991 Jul; 325(2):110-7. PubMed ID: 2052044
[No Abstract] [Full Text] [Related]
16. Economic assessment of different modalities of immunoglobulin replacement therapy.
Membe SK; Ho C; Cimon K; Morrison A; Kanani A; Roifman CM
Immunol Allergy Clin North Am; 2008 Nov; 28(4):861-74, x. PubMed ID: 18940579
[TBL] [Abstract][Full Text] [Related]
17. The patient: Emerging clinical applications of intravenous immunoglobulin.
Harvey RD
Pharmacotherapy; 2005 Nov; 25(11 Pt 2):85S-93S. PubMed ID: 16229679
[TBL] [Abstract][Full Text] [Related]
18. [Immunotherapy with immunoglobulins].
Briese V; Straube W
Zentralbl Gynakol; 1984; 106(24):1557-71. PubMed ID: 6085201
[TBL] [Abstract][Full Text] [Related]
19. Antibody mediated immunity: diagnosis and treatment of deficiency syndromes.
Rich KC
Compr Ther; 1979 Jun; 5(6):62-8. PubMed ID: 455936
[No Abstract] [Full Text] [Related]
20. [Secondary immunodeficiencies].
Giraldo Castellano P
Sangre (Barc); 1999 Apr; 44(2):155-61. PubMed ID: 10382325
[No Abstract] [Full Text] [Related]
[Next] [New Search]
